Yuhan Outlines Clinical Progress for Oral Targeted Anticancer Candidate YH42946 at WCLC 2026
Yuhan Corporation has detailed the status and trial design of the ongoing Phase 1/2 clinical study for YH42946, an oral targeted anticancer candidate...
Search results for "HER2"
Why Stage 3 Breast Cancer Doesn’t Always Mean Immediate Surgery
“Shouldn’t it be removed as soon as possible — even a day sooner?” This reaction is common among patients and their families following a cancer...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results
Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
Walking 30 Minutes a Day May Lower Breast Cancer Risk in Young Women
A new study reports that walking for just 30 minutes a day can create an anticancer environment in the blood and...
Why Breast Cancer Patients Should Get Brain MRIs Even Without Symptoms
Study results suggest that some breast cancer patients should receive regular brain MRI (magnetic resonance imaging)...
A Ray of Hope: ‘Low Expression’ Changes the Landscape of Breast Cancer Treatment
The treatment landscape for metastatic breast cancer is undergoing a significant shift.
"Breast Cancer Diagnosis, It's Too Early to Give Up" A Doctor's Calm Comfort
"Many breast cancer patients struggle with the process of fighting the disease. This is likely due to the thought that...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short
Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition
A new oral therapy is now available for patients with ROS1-positive lung cancer whose disease has progressed following...
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio
Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology...